Word

JOHNSON & JOHNSON

Status

Pending

Status Code

686

Status Date

Tuesday, August 27, 2024

Serial Number

98179225

Mark Type

5

Filing Date

Thursday, September 14, 2023

Published for Opposition

Tuesday, August 27, 2024

Trademark Owner History

Johnson & Johnson - Owner At Publication

Classifications

41 Educational services, namely, providing classes, seminars, workshops, presentations, webinars and conferences to the public and to professionals on the subjects of all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products

9 Downloadable and recorded computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products of all kinds; optical lenses for vision correction; contact lenses; eyeglass lenses

16 Printed matter, namely, articles, brochures, pamphlets, and newsletters containing information in the fields of health, wellness, and the development and use of pharmaceuticals, medicaments and medical products

5 Pharmaceutical and medicinal preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers; chemical, biochemical and biological preparations and agents for medical purposes, namely for use in orthopedic surgeries; diagnostic preparations for medical use; medical dressings; hemostatic agents for surgical use; drug delivery agents in the form of compounds, capsules, powders, dissolvable films, or liquids that facilitate the delivery of a wide range of pharmaceuticals and pharmaceutical preparations; contact lens disinfecting, cleaning, storing and rewetting solutions

44 Medical services and health care; provision of medical information; providing medical and healthcare information to patients and healthcare professionals concerning pharmaceutical products, medical devices, medical diseases and disorders and related treatments; gene and stem cell therapy medical treatment services

10 Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; orthopedic articles, namely, shoulder, hip, knee, spine, foot and ankle prostheses; suture materials; surgical robots and surgical robotic instruments; surgical visualization systems comprised primarily of medical imaging apparatus for use in surgical procedures and also incorporating computer hardware and display monitors for video processing and image management during surgical procedures

42 Scientific research for medical and healthcare purposes; research and development services in the fields of drug discovery, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials for others; scientific research consulting; providing scientific information in the field of laboratory technology; medical laboratory services; medical and pharmacological research services; providing online non-downloadable computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products

The mark consists of the word "JOHNSON" followed by an ampersand symbol and the word "JOHNSON".
JOHNSON AND JOHNSON
Color is not claimed as a feature of the mark.

Trademark Events

Sep 18, 2023

New Application Entered

Oct 3, 2023

New Application Office Supplied Data Entered

Apr 3, 2024

Assigned To Examiner

Apr 3, 2024

Non-Final Action Written

Apr 3, 2024

Non-Final Action E-Mailed

Apr 3, 2024

Notification Of Non-Final Action E-Mailed

Jun 26, 2024

Correspondence Received In Law Office

Jun 26, 2024

Teas/Email Correspondence Entered

Jun 26, 2024

Teas Response To Office Action Received

Jul 18, 2024

Examiners Amendment E-Mailed

Jul 18, 2024

Approved For Pub - Principal Register

Jul 18, 2024

Notification Of Examiners Amendment E-Mailed

Jul 18, 2024

Examiners Amendment -Written

Aug 7, 2024

Notification Of Notice Of Publication E-Mailed

Aug 27, 2024

Published For Opposition

Aug 27, 2024

Official Gazette Publication Confirmation E-Mailed

Jul 18, 2024

Examiner's Amendment Entered